Lung cancer organoids: the rough path to personalized medicine

HIGHLIGHTS

  • who: Rachele Rossi and collaborators from the Department of Oncology and Molecular Medicine, Istituto Superiore di Sanitu00e0, Viale Regina Elena, Rome, Italy Department of Surgical Sciences, Policlinico Umberto I, Sapienza University of Rome, Viale del Policlinico , have published the research: Lung Cancer Organoids: The Rough Path to Personalized Medicine, in the Journal: Cancers 2022, 14, 3703. of /2022/
  • future: The advent of three-dimensional culture technologies has opened new perspectives to recapitulate in vitro individualized tumor features and to anticipate treatment efficacy.

SUMMARY

    Lung cancer is broadly classified into two major . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?